NCT04404894View on ClinicalTrials.gov

Long-Term Prospective Registry in Prostate Cancer Patients From Diverse Urology Practice Settings Following Prolaris® Testing

Active, not recruitingOBSERVATIONAL

Enrollment

500

Participants

Timeline

Start Date

April 30, 2020

Primary Completion Date

November 30, 2029

Study Completion Date

November 30, 2029

Conditions

Prostate Cancer

Trial Locations (7)

21218

Johns Hopkins University, Baltimore

34205

Manatee Medical Research Institute, Bradenton

35209

Urology Centers of Alabama, Homewood

37232

Vanderbilt University Medical Center, Nashville

38018

The Urology Group, Memphis

60440

UroPartners, LLC, Westchester

90822

VA Long Beach Healthcare System, Long Beach

All Listed Sponsors

lead

Myriad Genetic Laboratories, Inc.

INDUSTRY

NCT04404894 - Long-Term Prospective Registry in Prostate Cancer Patients From Diverse Urology Practice Settings Following Prolaris® Testing | Biotech Hunter | Biotech Hunter